Skip to main content
Premium Trial:

Request an Annual Quote

Chris Ashton, David Evjen


Chris Ashton has become CEO of Etiologics in Oxford, UK. He joins the company from Orchid Bioscience, where he was CEO. Prior to that, he was commercial director of Inpharmatica and, previously, business development and marketing director at Oxford GlycoSciences.

At OGS, Ashton was responsible for initiating and negotiating partnerships with pharmaceutical and biotech companies. He also helped the company go public on the London Stock Exchange and raise $40 million.

Ashton also spent seven years at Applied Biosystems Europe. Ashton holds a BSc in biochemistry and a PhD in organic chemistry from the University of Manchester Institute of Science and Technology, and did postdoctoral research at the Massachusetts Institute of Technology. Etiologics provides novel mouse strains that can be used as disease models.

David Evjen has become CEO of Technologene, a startup company based in Lose Gatos, Calif. Evjen is the co-founder and former CEO of Med-Cor and Staff Outsourcing Solutions. He will be responsible for business development and focusing the company’s strategy, as well as guiding legal and public affairs functions. Technologene owns a patent for a process to produce industrial-grade proteins.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.